Perioperative Durvalumab with Neoadjuvant Chemotherapy in Operable Bladder Cancer.

已完结 10 由王志威发布于 2025/7/7 14:15:21

DOI:10.1056/NEJMoa2408154
作者：Thomas Powles,?James W F Catto,?Matthew D Galsky,?Hikmat Al-Ahmadie,?Joshua J Meeks,?Hiroyuki Nishiyama,?Toan Quang Vu,?Lorenzo Antonuzzo,?Pawel Wiechno,?Vagif Atduev,?Ariel G Kann,?Tae-Hwan Kim,?Cris
文献类型：期刊论文
补充材料：只需要正文

New England Journal of Medicine (NEJM)

Abstract：Background: Neoadjuvant chemotherapy followed by radical cystectomy is the standard treatment for cisplatin-eligible patients with muscle-invasive bladder cancer. Adding perioperative immuno

应助信息

求助已完结，文件已删除 如有需求请重新发布求助一键发布

感谢使用Book学术
本站所有文献仅供个人学习和参考，请勿将文件进行传播。共同遵守网站规定和相关知识产权规定。

上一个求助:其它数据库Naturally Fractured Carbonate Reservoir Characterization: A Case Study of a Mature High-Pour Point Oil Field in Hungary 下一个求助:其它数据库Optimal cutoffs of fatty liver index and hepatic steatosis index in diagnosing pediatric MASLD